Welcome to VivaScope.com

To view content for your location, please visit Caliber I.D.
If you are not from the U.S. please visit the international site.

Caliber I.D.

back to all news

New appearance for the global brand VivaScope.

May 2023 – VivaScope is proud to announce its new modern brand appearance. This refreshed look is a reflection of our commitment to innovation, technology, and customer service.

Take a closer look:

Our new brand appearance combines modern design elements and innovative technology to create a seamless and user-friendly experience for all of our customers. The sleek and sophisticated design of our new brand identity reflects our commitment to staying at the forefront of the ever-changing technology landscape. “We are excited to unveil our new modern brand appearance,” says Giuseppe Solomita, Director Sales & Marketing.

New emblem

Focusing on white color. For flexible use in multiple platforms.

We invite you to experience our new modern brand appearance and to discover the innovative technology that we have to offer.

New print layout.

With the two color scheme.

This refresh is a testament to our dedication to innovation and excellence in all aspects of our business.

Website.

Modern & intuitiv.

The new brand appearance will be launched across all of our platforms, including our website, social media, and marketing materials. We are confident that our new look will help us to continue to excel in the global technology industry.

Attachements

the VivaScope 2500 confocal microscopy brochures

Visit Download Area

Contact Person:

Mr. Solomita Giuseppe
Director Marketing & Sales

News

Fluorescence Confocal Microscopy on Liver Specimens for Full Digitization of Transplant Pathology

September 2023 – Rapid evaluation of donor liver specimens for transplantation using the VivaScope® 2500 Technology

News

Milestone at Vienna General Hospital: VivaScope revolutionises cancer diagnosis and treatment in Austria

In Austria, around 42,000 people are diagnosed with cancer every year. Although this is a matter of health and therefore the greatest human good, the analogue frozen section – a technique first used in 1895 – is still considered the gold standard for intraoperative pathological assessment when removing tumour tissue. With its “Ex Vivo” technology, the company VivaScope is bringing about a fundamental medical revolution. Thanks to digital optical sections, tumour tissue can be removed more efficiently than ever before and assessed within five minutes using telemedicine. The VivaScope 2500 is now being used for the first time in the field of dermatology at Vienna General Hospital.

News

Meilenstein im Wiener AKH: VivaScope revolutioniert die Krebsdiagnose und Behandlung in Österreich

In Österreich erkranken jährlich etwa 42.000 Menschen neu an Krebs. Obwohl es hier um die Gesundheit und damit um das höchste menschliche Gut geht, gilt bei der Entfernung von Tumorgewebe der analoge Gefrierschnitt – eine 1895 erstmals durchgeführte Technik – noch immer als Goldstandard der intraoperativen pathologischen Beurteilung. Das Unternehmen VivaScope sorgt hier mit der „Ex Vivo“-Technologie für eine grundlegende medizinische Revolution. Dank digital optischer Schnitte kann Tumorgewebe effizienter denn je entfernt und binnen fünf Minuten auch mittels Telemedizin beurteilt werden. Am Wiener AKH kommt nun erstmals das VivaScope 2500 im Bereich Dermatologie zur Anwendung.